Biancolella, M. et al. provide a comprehensive COVID-19 2022 update that discusses the transition of the pandemic into its endemic phase. This significant analysis was published in Human Genomics detailing the evolving dynamics of the virus and implications for public health strategies. 16, 19 (2022).
Nesteruk, I. presents a detailed overview of the endemic characteristics of SARS-CoV-2 infection. This crucial research highlights how the virus has adapted and is now behaving similarly to other endemic respiratory viruses. The findings were published in Scientific Reports. 13, 14841 (2023).
Watson, O. J. et al. conducted a mathematical modeling study that examines the global impact of the first year of COVID-19 vaccination. Their findings, which illustrate both the successes and challenges of vaccine distribution and uptake across different regions, were published in The Lancet Infectious Diseases. 22, 1293–1302 (2022).
Savinkina, A. et al. conducted a modeling study that estimates the deaths averted and evaluates the cost-effectiveness of mRNA COVID-19 vaccination in low-income and lower-middle-income countries during the Omicron variant era. This critical research sheds light on the necessity of equitable vaccine distribution to mitigate health disparities. Their findings were published in BMJ Open. 12, e061752 (2022).
Wilks, S. H. et al. focused on mapping the antigenic relationships and serological responses associated with SARS-CoV-2. This research provides valuable insights into how different variants interact with the immune system, published in Science. 382, eadj0070 (2023).
Hachmann, N. P. et al. reveal important findings regarding the neutralization escape by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5. This research is crucial as it sheds light on the virus’s ability to evade immune responses resulting from previous infections and vaccinations. Published in The New England Journal of Medicine. 387, 86–88 (2022).
Cao, Y. et al. documented that Omicron demonstrates the ability to escape the majority of existing neutralizing antibodies directed against SARS-CoV-2. This research is vital for understanding the persistence and adaptability of the virus. The findings are published in Nature. 602, 657–663 (2022).
How effective are current COVID-19 vaccines against the Omicron subvariants BA.2.12.1, BA.4, and BA.5 as reported in recent studies?
SARS-CoV-2%20Omicron%20Subvariants%20BA.2.12.1%2C%20BA.4%2C%20and%20BA.5&journal=The%20New%20England%20Journal%20of%20Medicine&doi=10.1056%2FNEJMc2206576&volume=387&publication_year=2022&author=Hachmann%2CNP”>
Google Scholar
